Metabolic
MOTS-c
Research listing. Not an approved medicine.
A mitochondrial-derived peptide studied for cellular energy regulation, glucose metabolism, insulin sensitivity, and exercise-related metabolic adaptations. Human therapeutic benefits remain unproven.
Vial size
CA$58
Estimated retail midpoint, CAD
Research-use only. Not for human or veterinary administration. Availability depends on applicable regulations, including in Canada. Prices are estimates, not verified market averages. Descriptions are informational and do not imply Health Canada approval or proven clinical effectiveness. Many listed compounds are investigational or not authorized for human use in Canada.
More in Metabolic
Metabolic · BC-16
Retatrutide
Investigational. Not an approved medicine. This listing is not a dosing guide.
CA$103
Estimated retail midpoint
Metabolic · BC-17
Tirzepatide
An approved medicine. This listing is not a prescription or a dosing guide.
CA$68
Estimated retail midpoint
Metabolic · BC-18
Semaglutide
An approved medicine. This listing is not a prescription or a dosing guide.
CA$110
Estimated retail midpoint